HC Wainwright Reiterates “Buy” Rating for Chimerix (NASDAQ:CMRX)
Chimerix (NASDAQ:CMRX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $11.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s price objective would indicate a potential upside of 116.54% from the company’s current […]
Chimerix (NASDAQ:CMRX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $11.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s price objective would indicate a potential upside of 116.54% from the company’s current […]
